CD47 and neoplasm: Moreover, it has been reported that SIRPα inhibition induced macrophage chemokine secretion, stimulated tumor nest T cell recruitment and increased antitumor T cell responses.44 Collectively, the above studies suggest that targeting the SIRPα–CD47 immune checkpoint could bridge innate and adaptive immunity and may induce a more durable immune response.